Adam J Olszewski

Summary

Affiliation: Brown University
Country: USA

Publications

  1. pmc Evolution of Management and Outcomes in Waldenström Macroglobulinemia: A Population-Based Analysis
    Adam J Olszewski
    Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island, USA Division of Hematology Oncology, Rhode Island Hospital, Providence, Rhode Island, USA
    Oncologist . 2016
  2. doi request reprint Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data Base
    Adam J Olszewski
    Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA
    Cancer Causes Control 26:1163-72. 2015
  3. doi request reprint Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma
    Adam J Olszewski
    The Cancer Center, Memorial Hospital of Rhode Island, 111 Brewster Street, Pawtucket, RI 02860, United States Electronic address
    Leuk Res 38:866-73. 2014
  4. pmc Paroxysmal nocturnal hemoglobinuria presenting with a left intraventricular thrombus in a patient with prior thymoma and aplastic anemia
    Yazan Migdady
    Division of Hematology and Oncology, Memorial Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, RI, United States of America
    Clin Med Insights Oncol 5:343-8. 2011
  5. doi request reprint Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma
    Adam J Olszewski
    Division of Hematology Oncology, Memorial Hospital of Rhode Island, Pawtucket, RI, USA
    Ann Hematol 93:449-58. 2014
  6. doi request reprint Radiation therapy administration and survival in stage I/II extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue
    Adam J Olszewski
    The Cancer Center at Memorial Hospital of Rhode Island, Pawtucket, Rhode Island Electronic address
    Int J Radiat Oncol Biol Phys 88:642-9. 2014
  7. pmc Comparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare database
    A J Olszewski
    The Cancer Center at Memorial Hospital of Rhode Island, Pawtucket, RI 02860, USA
    Ann Oncol 24:1352-9. 2013
  8. doi request reprint Effects of adjuvant chemotherapy in HER2-positive or triple-negative pT1ab breast cancers: a multi-institutional retrospective study
    Adam J Olszewski
    Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA
    Breast Cancer Res Treat 138:215-23. 2013
  9. doi request reprint Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database
    Adam J Olszewski
    Division of Hematology and Oncology, Memorial Hospital of Rhode Island, Pawtucket, RI 02860, USA
    Cancer 119:629-38. 2013
  10. doi request reprint Survival outcomes with and without splenectomy in splenic marginal zone lymphoma
    Adam J Olszewski
    Division of Hematology Oncology, Memorial Hospital of Rhode Island, The Warren Alpert Medical School of Brown University, Providence, Rhode Island
    Am J Hematol 87:E119-22. 2012

Collaborators

Detail Information

Publications22

  1. pmc Evolution of Management and Outcomes in Waldenström Macroglobulinemia: A Population-Based Analysis
    Adam J Olszewski
    Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island, USA Division of Hematology Oncology, Rhode Island Hospital, Providence, Rhode Island, USA
    Oncologist . 2016
    ..Its management largely relies on small phase II trials and it is unclear how their results translate into clinical practice in the community...
  2. doi request reprint Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data Base
    Adam J Olszewski
    Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA
    Cancer Causes Control 26:1163-72. 2015
    ..We evaluated performance characteristics of the clinically derived International Prognostic Index (IPI) and revised IPI (R-IPI) with a regression model-based score using the National Cancer Data Base...
  3. doi request reprint Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma
    Adam J Olszewski
    The Cancer Center, Memorial Hospital of Rhode Island, 111 Brewster Street, Pawtucket, RI 02860, United States Electronic address
    Leuk Res 38:866-73. 2014
    ..The advantage was largest for DLBCL of the spleen, liver and lung. Conversely, it was not evident for thyroid or testicular lymphomas. Compared with nodal DLBCL, spleen was the only site with significantly better prognosis after R-CHOP. ..
  4. pmc Paroxysmal nocturnal hemoglobinuria presenting with a left intraventricular thrombus in a patient with prior thymoma and aplastic anemia
    Yazan Migdady
    Division of Hematology and Oncology, Memorial Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, RI, United States of America
    Clin Med Insights Oncol 5:343-8. 2011
    ..The literature regarding the interplay between autoimmunity and immunosuppression, aplastic anemia, thymoma and the emergence of PNH is reviewed...
  5. doi request reprint Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma
    Adam J Olszewski
    Division of Hematology Oncology, Memorial Hospital of Rhode Island, Pawtucket, RI, USA
    Ann Hematol 93:449-58. 2014
    ..Single-agent rituximab may offer the most favorable risk/benefit ratio in this population...
  6. doi request reprint Radiation therapy administration and survival in stage I/II extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue
    Adam J Olszewski
    The Cancer Center at Memorial Hospital of Rhode Island, Pawtucket, Rhode Island Electronic address
    Int J Radiat Oncol Biol Phys 88:642-9. 2014
    ..To determine the factors associated with the use of radiation therapy and associated survival outcomes in early-stage marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT)...
  7. pmc Comparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare database
    A J Olszewski
    The Cancer Center at Memorial Hospital of Rhode Island, Pawtucket, RI 02860, USA
    Ann Oncol 24:1352-9. 2013
    ..Therapy for gastric marginal zone (MALT) lymphoma is largely based on single-arm trials. This observational study compared survival with radiotherapy, rituximab and combination chemoimmunotherapy in this disease...
  8. doi request reprint Effects of adjuvant chemotherapy in HER2-positive or triple-negative pT1ab breast cancers: a multi-institutional retrospective study
    Adam J Olszewski
    Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA
    Breast Cancer Res Treat 138:215-23. 2013
    ..While limited by the small number of events, our analysis does not support the increasingly prevalent practice of administering adjuvant chemotherapy in this population without more accurate prognostic and predictive factors...
  9. doi request reprint Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database
    Adam J Olszewski
    Division of Hematology and Oncology, Memorial Hospital of Rhode Island, Pawtucket, RI 02860, USA
    Cancer 119:629-38. 2013
    ..The prognosis of patients with MALT lymphoma varies according to the anatomical site of origin...
  10. doi request reprint Survival outcomes with and without splenectomy in splenic marginal zone lymphoma
    Adam J Olszewski
    Division of Hematology Oncology, Memorial Hospital of Rhode Island, The Warren Alpert Medical School of Brown University, Providence, Rhode Island
    Am J Hematol 87:E119-22. 2012
    ..66)or overall survival was detectable. The results strengthen the notion that, with the availability of safe and effective alternatives, splenectomy should no longer be considered the treatment of choice in SMZL...
  11. doi request reprint Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database
    Jorge J Castillo
    Division of Hematology and Oncology, Alpert Medical School of Brown University, Rhode Island Hospital The Miriam Hospital, Providence, Rhode Island
    Cancer 119:3672-9. 2013
    ..This study evaluated prognostic factors for survival in adult patients with BL and a potential outcome improvement over the past decade in a population-based cohort...
  12. doi request reprint Adjuvant chemotherapy in T1a/bN0 HER2-positive or triple-negative breast cancers: application and outcomes
    Yazan Migdady
    The Warren Alpert Medical School of Brown University, Providence, RI 02912, USA The Cancer Center at Memorial Hospital of Rhode Island, 111 Brewster St, Pawtucket, RI 02860, USA
    Breast 22:793-8. 2013
    ..In a univariate analysis administration of adjuvant chemotherapy was not associated with a significantly better recurrence rate (P = 0.33)...
  13. doi request reprint Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapy
    Adam J Olszewski
    aAlpert Medical School of Brown University, Providence bDepartment of Medicine, Memorial Hospital of Rhode Island, Pawtucket, Rhode Island cDivision of Hematologic Malignancies, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA
    AIDS 30:787-96. 2016
    ..Our objective was to investigate the proportion of Americans who received curative chemotherapy for this disease, and compare their survival with HIV-negative cases using population data...
  14. doi request reprint Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis
    Kenneth D Bishop
    Department of Medicine, Alpert Medical School of Brown University, Providence, RI Division of Hematology Oncology, Rhode Island Hospital, Providence, RI
    Int J Cancer 134:2961-71. 2014
    ..Because of poor outcomes in MM, studies of systemic therapy are warranted regardless of the extent of disease at presentation. ..
  15. ncbi request reprint Risk Factors for Early Death After Rituximab-Based Immunochemotherapy in Older Patients With Diffuse Large B-Cell Lymphoma
    Adam J Olszewski
    From the Department of Medicine, Alpert Medical School of Brown University, and Division of Hematology Oncology, Rhode Island Hospital, Providence, Rhode Island and Division of Hematologic Malignancies, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts From the Department of Medicine, Alpert Medical School of Brown University, and Division of Hematology Oncology, Rhode Island Hospital, Providence, Rhode Island and Division of Hematologic Malignancies, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts
    J Natl Compr Canc Netw 14:1121-9. 2016
    ..Our objective was to quantify the risk and identify factors associated with death during the first cycle of immunochemotherapy in this population...
  16. doi request reprint Disparate survival outcomes after front-line chemoimmunotherapy in older patients with follicular, nodal marginal zone and small lymphocytic lymphoma
    Adam J Olszewski
    Division of Hematology Oncology, Memorial Hospital of Rhode Island, Pawtucket, RI, USA
    Leuk Lymphoma 56:942-50. 2015
    ..Choice of front-line chemotherapy may thus impact survival in older patients with indolent lymphomas, and heterogeneity by histology should be accounted for in clinical trials. ..
  17. doi request reprint Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base
    Adam J Olszewski
    Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island
    Cancer 122:2689-97. 2016
    ..Antiviral therapy has altered the prognosis of patients with human immunodeficiency virus (HIV)-associated non-Hodgkin lymphoma (NHL), but patterns of lymphoma-directed therapy in the community are unknown...
  18. ncbi request reprint Adjuvant Therapy for Resected Gallbladder Cancer: Analysis of the National Cancer Data Base
    Kalyan C Mantripragada
    Division of Hematology Oncology, Rhode Island Hospital, Providence, RI KCM, AJO Department of Medicine, Memorial Hospital of Rhode Island, Pawtucket, RI FH, HS Department of Medicine, Alpert Medical School of Brown University, Providence, RI KCM, FH, AJO
    J Natl Cancer Inst 109:. 2017
    ..Management of resected gallbladder cancer relies on single-arm trials and retrospective observations. Our objective was to evaluate adjuvant therapy in a nationwide data set using causal inference methods to address sources of bias...
  19. doi request reprint Race-specific features and outcomes of nodular lymphocyte-predominant Hodgkin lymphoma: Analysis of the National Cancer Data Base
    Adam J Olszewski
    Department of Medicine, The Warren Alpert Medical School of Brown University, Providence, Rhode Island
    Cancer 121:3472-80. 2015
    ..The authors compared clinical features, treatments, and survival of black and white patients with NLPHL using the National Cancer Data Base...
  20. doi request reprint Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base
    Adam J Olszewski
    Adam J Olszewski and Rajesh Shrestha, Alpert Medical School of Brown University, Providence Adam J Olszewski and Rajesh Shrestha, Memorial Hospital of Rhode Island, Pawtucket, RI and Jorge J Castillo, Dana Farber Cancer Institute Harvard Medical School, Boston, MA
    J Clin Oncol 33:625-33. 2015
    ..Our objective was to define factors affecting treatment selection and resulting survival outcomes in the United States...
  21. doi request reprint Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis
    Hammad Shafqat
    1 Alpert Medical School, Brown University, Providence, Rhode Island 2 Department of Medicine, Memorial Hospital of Rhode Island, Pawtucket, Rhode Island
    Dis Colon Rectum 58:294-303. 2015
    ..High-grade neuroendocrine carcinoma is a rare colorectal pathology described in a case series. The role of surgery in this disease has been questioned...
  22. doi request reprint Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study
    Shihab Ali
    Alpert Medical School of Brown University, Providence, RI, USA
    Leuk Lymphoma 55:1570-7. 2014
    ..In conclusion, the histologic classification retains a significant prognostic value in HL and the disparities between the subtypes warrant customized treatment and surveillance strategies...